基于产业集群视角中国生物医药产业创新能力的提升  

Improvement of Innovation Ability of China's Biomedical Industry Based on Perspective of Industrial Cluster

作　　者：濮润[1] 桑晓冬 张大璐[1] 武瑞君 郭伟[1] 魏巍 范玲 PU Run;SANG Xiaodong;ZHANG Dalu;WU Ruijun;GUO Wei;WEI Wei;FAN Ling(China National Center for Biotechnology Development,Beijing 100039,China)

机构地区：[1]中国生物技术发展中心,北京100039

出　　处：《医药导报》2022年第6期905-910,共6页Herald of Medicine

基　　金：中国社会科学基金项目(19CJY003)。

摘　　要：生物医药产业是国家重点培育发展的产业方向之一,并被列入国家战略性新兴产业集群发展工程。产业集群是推动生物医药产业创新发展的重要载体,对于实现健康中国战略具有重要意义。该文基于产业集群的视角,综合分析了产业集群在生物医药产业创新发展中的作用;结合我国生物医药产业集群的发展现状和不足,并针对创新能力提升提出了相应的对策和建议,以期为提高我国生物医药产业在科技、经济方面的国际竞争力提供参考。Biomedicine industry,as a key field that gains national cultivation and development,has been included in the national strategic emerging industry cluster development projects in China.Industrial cluster is an important carrier to promote the innovation and development of biomedical industry,which is of great significance to the realization of healthy China strategy.Based on the perspective of industrial cluster,this paper comprehensively analyzes the role of industrial cluster in the innovation and development of biomedical industry.And combined with the development status and deficiencies of biomedical industry clusters in China,corresponding countermeasures and suggestions are put forward for the improvement of innovation capacity,in order to provide reference to strengthen the international competitiveness of China's biomedical industry in science&technology and economy.

关 键 词：生物医药 产业集群 创新发展 

分 类 号：R956[医药卫生—药学]